Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability, Safety, and Pharmacokinetics of Repeated Sublingual Doses of Lobeline

NCT00519259 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT00519259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00519259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability, Safety, and Pharmacokinetics of Repeated Sublingual Doses of Lobeline
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2006
Completion date
Not reported
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine dependence